Triptolide Enhances the Tumoricidal Activity of TRAIL Against Renal Cell Carcinoma

Renal cell carcinoma (RCC) is resistant to traditional cancer therapies, and metastatic RCC (mRCC) is incurable. The shortcomings in current therapeutic options for patients with mRCC provide the rationale for the development of novel treatment protocols. TNF-related apoptosis-inducing ligand (TRAIL...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:FEBS J
Huvudupphovsmän: Brincks, Erik L., Kucaba, Tamara A., James, Britnie R., Murphy, Katherine A., Schwertfeger, Kathryn L., Sangwan, Veena, Banerjee, Sulagna, Saluja, Ashok K., Griffith, Thomas S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715782/
https://ncbi.nlm.nih.gov/pubmed/26426449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.13532
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk